Garmin API Terms: Why Intervals Pro Shut Down and Who's Next
New Garmin API terms limit how platforms pass on your data, and Intervals Pro has already shut down. Which apps and AI tools are at risk, and what still works.
Polar H10 Resonance Breathing: SYMPATHETIC Adds HRV and ECG
SYMPATHETIC is a free iPhone app that pairs Polar H10 resonance breathing with live HRV and ECG views. What it measures, its limits, and who it suits.
Mito's $249 Heart Scan: What a Coronary Calcium Score Actually Tells You
Mito Health now offers a $249 coronary artery calcium scan, which shows existing arterial plaque. Who the 2026 ACC/AHA guidelines say should consider one.
Oura Ring Just Connected to Xella's Women's Health Platform — This Is What Clinical Interpretation of Wearable Data Actually Looks Like
Xella now pulls Oura Ring sleep, HRV, and temperature data into clinical interpretation alongside hormone tests, covering 130+ female-specific conditions.
Apple Watch Series 12 Can Now Estimate Your Biological Age. Here's What It Actually Measures.
Apple Watch's new Longevity tab introduces a Health Age metric built from VO2 max, resting heart rate, sleep quality, and HRV — plus optional lab inputs. The hardware update delivers 24x faster HRV refresh and splits HRV into two clinically distinct signals.
Mito Health Hits 1 Million Lab Tests — and the $9 Membership Model Is Why It Matters
Mito Health, the direct-to-consumer diagnostics platform, has processed over 1 million lab tests at cost with a $9/month flat-fee membership. The milestone marks a shift in how serious longevity practitioners access biomarker data — no insurance, no referrals, no per-test markup.
Blood Pressure and Longevity: What Peter Attia's AMA #48 Gets Right About Measurement
Blood pressure is one of three primary drivers of atherosclerosis — yet most people check it once a year. Attia's AMA #48 rebroadcast makes the case for treating it as a daily metric.
Oura Health Files for IPO at $16 Billion: What a Smart Ring's Valuation Tells Us About Biometric Data
Oura Health is targeting a $3B raise at a $16B valuation — a 45% jump from 18 months ago — built on a hardware-plus-subscription model that turns sleep and recovery data into recurring revenue.
Quest Diagnostics Is Now Selling Biological Age: What the $29 Test Actually Measures
Humanity's biological age test is now a $29 add-on at 2,000 Quest locations. The model behind it tracked 306,000+ people for 11.6 years and covers six body systems.
KardiaMobile 6L: The Study That Found Twice as Many Arrhythmias as Hospital Monitors
A University of Rochester cohort study published in JACC Advances found AliveCor's KardiaMobile 6L detected nearly twice the arrhythmia rate of traditional short-duration ECG monitors in 350 patients over 30 days.
Gum Recession: Why the Habits You Think Are Helping May Be Hurting
Gum recession affects 88% of adults 65+, and aggressive brushing is a leading cause. Why lost gum tissue never grows back — and the one technique change that matters.
Whole-Body MRI Is Leaving the Biohacker Bubble
EHE Health's partnership with Prenuvo brings whole-body MRI screening into 200+ preventive care clinics. What this transition from biohacker niche to medical infrastructure means for longevity-minded members.
Wonderfeel: What a 4,235% Growth Rate Signals for the NAD+ Supplement Market
The NAD+ longevity brand ranked No. 1 biotech on the 2026 Inc. 5000. The growth rate reflects a consumer longevity market that's moving faster than most industry observers expected.
Can AI Put the Cell Back Together? GenBio's Virtual Cell Model Tries
GenBio AI's AIDO Cell system creates a stateful virtual cell model — integrating DNA, RNA, and protein behavior — to predict how intervention sequences affect biological aging.
Function Health's AI Connector: Your Lab Results Just Became AI Training Data — For You
Function's new connector links 160+ personal lab results to ChatGPT, Claude, and Perplexity. Over 80% of members have at least one biomarker outside optimal range — now AI can reason over that directly.
GDF-15 and P-Tau217: The Biomarkers That Warn You Before You Feel Anything
New biomarker research is shifting the question from 'what's wrong?' to 'what's coming?' GDF-15 as a cellular stress signal and p-tau217 for pre-symptomatic Alzheimer's risk represent a new category of early detection — but their limitations matter as much as their promise.
Biological Age Clocks: The Regulatory Reckoning Is Coming
With $3.74 billion flowing into longevity biotech in Q1 2026 alone, investors are backing biological age diagnostics that regulators cannot yet validate. The collision between capital and clinical evidence is building.
GDF-15 and P-tau217: The Biomarkers That Signal Breakdown Before You Feel It
Two biomarkers — GDF-15 for cellular stress and P-tau217 for Alzheimer's risk — can flag physiological strain years before symptoms appear. Here's what they measure, what trends reveal, and why a single reading misses the point.
Blood Filtering Is the New Wellness Flex — And Viome Just Bought the Infrastructure
Viome's acquisition of Circulate Health pairs multi-omics biomarker testing with therapeutic plasma exchange. What this convergence means for longevity-focused consumers navigating an increasingly clinical wellness stack.
Protein Restriction for Kidney Disease: What the Evidence Actually Shows
Peter Attia reviews the MDRD trial and Cochrane data: the default CKD advice to restrict protein lacks the evidence base it's been given — and the biggest trial showed higher long-term mortality in the restriction group.
Aging Research Has Been Studying the Wrong Sex
The Reproductive Resilience Hypothesis, published in Cell, argues female biology holds the key to understanding longevity — but most aging research has treated it as experimental noise.
Human Longevity's $599 Genomics for All: What Clinical-Grade DNA Sequencing Gets You Now
Human Longevity sequences all 6.4 billion base pairs at $599 — and an AI layer re-alerts you as science evolves. What it covers, who it's actually for, and why the re-analysis matters more than the price.
The Bathroom as a Longevity Clinic: What Vivoo's Passive Monitoring Stack Changes
Vivoo's urinalysis platform and toilet-integrated hydration monitor embed daily biomarker collection into existing routines. What it covers, why passive beats active testing, and where this sits in a complete longevity stack.
NMR Blood Testing: One Blood Sample, Four Different Risk Scores
A single NMR blood scan reveals heart disease, insulin resistance, inflammation, and mortality risk — the inventor explains why one draw beats a standard panel.
Metabolic Health: Why GLP-1s Were Never the Whole Answer
GLP-1 drugs sparked the metabolic health boom, but the platforms building around it are betting the real product is what happens after the prescription.
Ultrahuman's Emerald Update Answers a Question Wearables Kept Ignoring
Ultrahuman's Emerald overhaul replaces spreadsheet-style metrics with a decision engine that tells you what to actually do next — plus a VO2 max algorithm validated to lab-grade accuracy.
Heat Training Boosts Hemoglobin — But Can It Make You Faster?
Heat training reliably raises hemoglobin mass by 2–5%. But 5 of 6 trials find no clear performance payoff in VO₂max or sport results. Here's what the evidence actually shows.
Dumbo Health Is Turning Sleep Into a Clinical Longevity Metric — Here's What That Means
Miami-based Dumbo Health launched Sleep Longevity: 51 blood biomarkers, wearable data, and physician care in one membership. The 90% of women with undiagnosed sleep apnea are the real target.
Scientists Reversed 'Permanent' Aging Damage in Human Tissue. Here's What Was Fixed.
A Nature Communications study showed an engineered enzyme (CMLase) removed advanced glycation end products from human arterial, skin, and lens tissue — reversing damage long considered irreversible.
Google's SensorFM: What a 1-Trillion-Minute Wearable Dataset Changes
Google's new foundation model for wearable sensors outperformed prior models on 34 of 35 health tasks — and what it means for the future of passive health monitoring.
Dry Fasting for 5 Days: What the Biometrics Actually Showed
A measured 5-day dry fast tracked with continuous glucose, ketones, HRV, InBody scans, and grip strength. What the data showed — and what the dehydration artifact gets wrong.
Fountain Life's $595 BASE Plan Is the Longevity Industry's Mass-Market Moment
Fountain Life's new BASE membership brings 100+ biomarkers, DEXA scan, and AI-guided clinician review to individuals for $595 — a significant shift from its ultra-premium roots.
C15:0: The Saturated Fat That Longevity Researchers Are Rethinking
Pentadecanoic acid — an odd-chain saturated fatty acid — is showing geroprotective properties that challenge blanket warnings against saturated fat, with initial research from Navy dolphin aging studies.
SystemAge 2.1: The First Biological Age Test with Separate Male and Female Models
Generation Lab's SystemAge 2.1 analyzes 460+ biomarkers across 21 organ systems using gender-specific algorithms — the most granular biological age measurement now available through clinical partners.
GARM's Klotho Longevity Residency Brought 22 Participants to Honduras. Here's What They're Testing.
A four-day longevity residency at the Kimpton Grand Roatán included a proprietary Klotho intervention, blood sampling before and after, and researchers from MIT and Harvard. GARM is betting that Klotho is the next longevity biomarker to watch.
Peter Attia: High HDL Cholesterol Doesn't Protect Your Heart. It Might Hurt It.
HDL-C has been called 'good cholesterol' for decades. Peter Attia's latest analysis unpacks why the clinical evidence never supported the label — and why very high HDL-C levels may signal elevated cardiovascular risk, not lower.
Lung Cancer Screening for Never-Smokers: What the Data Says
Guidelines don't recommend lung cancer screening for never-smokers — but the evidence gap is a policy artifact, not a scientific finding. Peter Attia makes the case for personalized assessment.
Menopause Tracking: Why the Average Is 9 Symptoms, Not 1 or 2
A Winona study of 100,000+ women found an average of nine simultaneous menopause symptoms — and 77.5% waited over a year before accessing care. The data reframes how practitioners should think about this life stage.
Your Complete Genome for $599: Human Longevity Inc. Bets on Consumer Genomics
Human Longevity Inc. now offers full whole-genome sequencing for $599 — down from ~$10,000 a decade ago — bundled with AI-powered multi-omics analysis across more than 50,000 conditions.
Ultrahuman M2 Live Makes Continuous Glucose Monitoring Mainstream
Ultrahuman's M2 Live pairs with Abbott's OTC Lingo CGM to bring prescription-free glucose tracking to anyone for $99/month — removing the biggest barrier to metabolic health monitoring.
Beacon Biosignals: AI Sleep Staging Is Moving Out of the Lab
Beacon Biosignals presented clinical validation data for its AI sleep staging algorithms at SLEEP 2026. What their EEG foundation model means for where consumer sleep tech is headed.
Clair Raises $11.6M to Build the First Continuous Hormone Monitor for Women
Clair's wrist-worn device uses 10 biosensors and 130+ proprietary biomarkers to infer estrogen, progesterone, LH, and FSH levels in real time — revealing 9 distinct hormonal sub-phases the traditional 4-phase model misses.
Forever Chemicals Are Accelerating Your Biological Age — Longevity Needs to Catch Up
Two peer-reviewed studies link PFAS exposure to accelerated epigenetic aging via C-reactive protein. The longevity field's focus on what to add ignores what to remove — and that gap is measurable.
Sky Labs' CART BP Pro Ring Heads to Europe After 260K+ South Korean Prescriptions
Sky Labs is launching its cuffless blood pressure monitoring ring in Europe and the UK, backed by CE-MDR certification and a 260,000+ prescription track record in South Korea.
Geroscience Is Rewriting the Logic of Disease Prevention
Thirty percent of centenarians escape major age-related disease entirely — not by treating conditions as they arrive, but by aging differently. Geroscience targets the shared biological mechanisms underlying multiple diseases simultaneously. Here's where the clinical evidence stands in 2026.
The Breast Cancer Screening Framework Peter Attia Uses — And Why Standard Mammogram Advice Falls Short
Risk-stratified screening starts with a formal risk assessment by age 25 — not when your doctor first orders a mammogram at 40. Peter Attia's framework explains why, and what the implementation failure actually looks like at scale.
Alamar's Dried Blood Spot Kit Makes Hospital-Grade Proteomics Work on a Fingerstick at Home
Alamar Biosciences' NULISA DBS Extraction Kit extends proximity ligation proteomics to dried blood spot samples—85–95% detectability, compatible with Capitainer and Mitra devices, ships standard mail.
InsideTracker Pivots to AI Platform: What the Terra Shift Means for Biohacking
InsideTracker is becoming Terra, a B2B AI platform licensing biomarker-based health guidance to wellness and healthcare companies. The consumer brand isn't gone — it's becoming infrastructure.
resbiotic Makes Shotgun Metagenomics an At-Home Gut Test
resbiotic's at-home gut health test uses shotgun metagenomic sequencing — the same method clinical researchers use — with HSA/FSA eligibility and a 60-90 day retesting cadence built around lifestyle optimization.
Glycans: The Aging Biomarker That Predicts Disease a Decade Early
IgG glycans explain 58% of age variance—more than telomeres—and predict cardiovascular events and diabetes onset up to 10 years early. Here's what that means.
4 Genetic Tests Worth Getting — And Why Most Aren't
Peter Attia's Episode #392 framework on genetic testing: the four high-penetrance tests that actually change clinical decisions, and why most DTC tests don't.
DEXA Scans Are Not All Equal: Fitnescity's New Clinical Standard
A DEXA scan at one clinic may not be comparable to another. Fitnescity's Clinical Integrity Standard defines what consistent body composition testing requires.
At-Home Finger-Prick Test Hits 86% Accuracy for Alzheimer's
Nature Medicine validated at-home p-tau217 finger-prick sampling at 86% accuracy. Here's what it means for early Alzheimer's detection.
Function Health: The Case for Testing Insulin Before You Need To
Function Health offers 160+ lab tests covering metabolic and hormonal markers that standard care skips — here's what the extra data actually tells you.
Lipid-Lowering Pharmacotherapy: The Decision That Actually Determines Outcomes
92 million Americans take statins, but which lipid-lowering drug you take matters less than matching it to your dominant cholesterol pathway. Here's the framework.
Your Immune System Can Now Have a Digital Twin — Here's What That Means
A Zurich clinic and Barcelona AI firm just launched the first commercial immune digital twin platform. It's early-stage, but the model it represents is where preventive health is heading.
Aging Clocks: What They Actually Measure (And Why Most Are Still Wrong)
Not all biological age clocks are equal. Learn why third-generation clocks like DunedinPACE outperform Horvath by orders of magnitude — and what to demand before paying for a test.
The Architecture of Continuous Biosensing: From Wearables to Woven Systems
Analyzing the 2026 shift toward multi-sensor biosensing platforms and the quantification of aging through the ARPA-H and WHOOP initiative.
Intrinsic Capacity: The New Benchmark for Biohacking Architecture
Analysis of the Stanford THRIVE coalition's push for measuring intrinsic capacity at scale and its implications for longevity protocols in 2026.
Biohacking Data Sovereignty: Owning Your Biological Identity
Why the future of biohacking depends on decentralized data storage and the elimination of centralized health platforms.
The Industrialization of Personal Biology: Beyond the Quantified Self
How biohacking is shifting from hobbyist self-experimentation to a rigorous data-driven industry.
The Data-Driven Evolution: Biohacking in 2026
Exploring the shift from anecdotal wellness to rigorous, data-driven personal health optimization.